Date | Time | Source | Headline | Symbol | Company |
01/23/2012 | 7:00AM | Zacks | European Setback for Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/20/2012 | 7:49AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/20/2012 | 7:43AM | Business Wire | Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/12/2012 | 12:15PM | Zacks | Allos Therapeutics Cut to Neutral - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/11/2012 | 8:15AM | Zacks | AMAG Q4 Sales Set to Disappoint - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/10/2012 | 8:11AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/10/2012 | 8:00AM | Business Wire | Allos Therapeutics Reports 2011 Financial Highlights and Key Business Priorities | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/23/2011 | 5:00PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/23/2011 | 4:51PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/21/2011 | 8:00AM | Business Wire | Allos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 4:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 4:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/15/2011 | 10:00AM | Zacks | AMAG's Feraheme Gets Canada Nod - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/08/2011 | 4:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/25/2011 | 7:15AM | Zacks | Allos Continues to Outperform - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/18/2011 | 8:00AM | Zacks | AMAG Hires Financial Advisor - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/17/2011 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/08/2011 | 8:30AM | Zacks | Allos Narrows Loss - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/08/2011 | 4:15AM | Zacks | Loss Shrinks at AMAG, CEO Departs - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/04/2011 | 5:05AM | Zacks | Company News for November 4, 2011 - Corporate Summary | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
11/03/2011 | 7:07AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |